Display Settings:

Format

Send to:

Choose Destination
    Curr Pharm Des. 2006;12(9):1129-45.

    Update on the pharmacokinetic aspects of antiretroviral agents: implications in therapeutic drug monitoring.

    Source

    University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice, 315 Cooke Hall, Buffalo, NY 14260, USA. slish@buffalo.edu

    Abstract

    The observed inter-individual variation in antiretroviral pharmacokinetics (PK) that results in a wide range of drug exposures from fixed-dose regimens has led to increasing interest in the clinical use of therapeutic drug monitoring (TDM) to individualize dosing of antiretroviral therapy (ART). The focus of this review is to provide an overview of literature available to support therapeutic drug monitoring among the current classes of antiretrovirals, suggest patient populations that may benefit from TDM and bring forth some of the limitations that may exist for widespread use of TDM in a traditional clinical setting.

    PMID:
    16515491
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk